India to Yemen: Omeprazole Export Trade Route

The India to Yemen Omeprazole corridor is one of India's established pharmaceutical export routes, with 266 shipments documented worth a combined $53.3M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 96% of all export value, reflecting the consolidated nature of India's omeprazole manufacturing sector.

Across 53 active suppliers, the average shipment value stands at $200.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 33.4%, placing it at rank #9 among India's top omeprazole export destinations globally.

On the import side, key buyers of Indian omeprazole in Yemen include CIPLAMEDICA PHARMACEUTICAL INDUSTRI, AL-JABAL DRUGS AND MEDICAL APPLIANC, MEDICA PHARMACEUTICAL INDUSTRIES LI and 63 others. CIPLAMEDICA PHARMACEUTICAL INDUSTRI is the single largest importer with 13 shipments valued at $50.0M USD.

India's omeprazole exports to Yemen are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 61 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 53 active exporters signals a competitive but concentrated market — buyers in Yemen benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, ZYDUS LIFESCIENCES LIMITED, BAL PHARMA LIMITED — together account for 98% of total trade value on this route. The average shipment value of $200.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as lomac 20 capsules (omeprazole 20 mg) (inv.qty.16380 pack 30x10s=4914000 nos) and lomac 20 capsules (omeprazole 20 mg) (inv.qty.4400 pack 30x10s=1320000 nos), suggesting that buyers in Yemen tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CIPLAMEDICA PHARMACEUTICAL INDUSTRI is the largest importer with 13 shipments worth $50.0M USD — representing 94% of all omeprazole imports from India on this route. A total of 66 buyers are active on this corridor.